Table 6.
The data of various diagnostic and decision parameters during the treatment of a typical NSCLC patient.
| CYFRA21-1 (μg/mL) |
CEA (μg/L) |
CA-125 (KU/L) |
NSE (μg/mL) |
CA242 (KU/L) |
PSA (μg/mL) |
HGH (μg/mL) |
Free-PSA (μg/mL) |
FERRITIN (KU/L) |
|
|---|---|---|---|---|---|---|---|---|---|
| 1 | 4.16 | 285.41 | 711.01 | 34 | 8 | 1.12 | 10.25 | 58.81 | 835.7 |
| 2 | 5.57 | 277.99 | 688.81 | 36 | 5 | 1.42 | 11.21 | 49.71 | 754.1 |
| 3 | 3.55 | 257.15 | 521.42 | 27 | 6 | 1.86 | 12.15 | 48.22 | 738.2 |
| 4 | 4.28 | 231.44 | 461.56 | 25 | 6 | 1.29 | 11.20 | 47.55 | 622.1 |
| 5 | 3.47 | 184.88 | 408.18 | 36 | 5 | 1.54 | 15.71 | 38.51 | 422.6 |
| 6 | 4.84 | 128.11 | 321.88 | 27 | 7 | 1.68 | 13.88 | 35.12 | 351.8 |
| 7 | 5.17 | 62.89 | 295.10 | 38 | 6 | 1.71 | 12.51 | 11.6 | 211.1 |
| 8 | 3.89 | 21.17 | 178.20 | 21 | 5 | 1.55 | 13.61 | 7.1 | 209.7 |